| HOME >> MEDICINE >> TECHNOLOGY |
15. EUROPE 99
A.Market Analysis 99
Cardiovascular Disease in Europe - A Perspective 99
Growth Bar Too Low 99
Two-Speed Europe 99
Stent Market's Merger Mania 100
Dampeners to Rapid Adoption of DES in Europe 100
Competitive Scenario 101
Table 46: Leading Players in the European Drug- Eluting
Stent Market (2010) - Percentage Breakdown of Share for
Johnson & Johnson, Boston Scientific, Medtronic, and Others
(includes corresponding Graph/Chart) 101
B.Market Analytics 102
Table 47: European Recent Past, Current & Future Analysis
for Coronary Stents by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales in US$ Million for
years 2009 through 2017 (includes corresponding Graph/Chart) 102
Table 48: European Recent Past, Current & Future Analysis
for Coronary Stents by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales in Thousand Units
for years2009 through 2017 (includes corresponding
Graph/Chart) 103
Table 49: European Historic Review for Coronary Stents by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales in US$ Million for years 2003 through 2008
(includes corresponding Graph/Chart) 104
Table 50: European Historic Review for Coronary Stents by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales in Thousand Units for years 2003 through
2008 (includes corresponding Graph/Chart) 105
Table 51: European 15-Year Perspective for Coronary Stents
by Geographic Region - Percentage Breakdown of Dollar
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |